Literature DB >> 33414992

Management of nephrotoxicity of chemotherapy and targeted agents: 2020.

Varsha Chiruvella1, Pavan Annamaraju2, Achuta K Guddati1.   

Abstract

Nephrotoxic effects of certain chemotherapeutic agents such as cisplatin and ifosfamide has been well documented and these effects are carefully managed by oncologists during their usage. The introduction of targeted agents has added a new challenge to cancer management as their nephrotoxic effects and associated management is in the process of being adopted by oncologists. This work is a compilation of side effects on the renal system due to various chemotherapeutic, immunotherapeutic and targeted agents followed by their recommended management. AJCR
Copyright © 2020.

Entities:  

Keywords:  Nephrotoxicity; acute kidney injury; chronic kidney disease; side effects; tumor lysis syndrome

Year:  2020        PMID： 33414992      PMCID： PMC7783750     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN： 2156-6976            Impact factor:   6.166


  108 in total

1.  Cetuximab-induced hypomagnesemia in patients with colorectal cancer.

Authors:  Marwan G Fakih; Gregory Wilding; Jeffrey Lombardo
Journal:  Clin Colorectal Cancer       Date:  2006-07       Impact factor: 4.481

2.  NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.

Authors:  Roshan J Thapa; Peirong Chen; Mitchell Cheung; Shoko Nogusa; Jianming Pei; Suraj Peri; Joseph R Testa; Siddharth Balachandran
Journal:  Mol Cancer Ther       Date:  2013-05-08       Impact factor: 6.261

3.  Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy.

Authors:  H O Cutting
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

Review 4.  Thrombotic Microangiopathy in Cancer.

Authors:  Ilene Ceil Weitz
Journal:  Semin Thromb Hemost       Date:  2019-04-30       Impact factor: 4.180

5.  Acute renal failure in critically ill patients: a multinational, multicenter study.

Authors:  Shigehiko Uchino; John A Kellum; Rinaldo Bellomo; Gordon S Doig; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Claudio Ronco
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

Review 6.  Nephrotic syndrome in adults: diagnosis and management.

Authors:  Charles Kodner
Journal:  Am Fam Physician       Date:  2009-11-15       Impact factor: 3.292

Review 7.  Renal toxicity of targeted therapies.

Authors:  Ronan J Kelly; Bertrand Billemont; Olivier Rixe
Journal:  Target Oncol       Date:  2009-05-06       Impact factor: 4.493

Review 8.  Mutant B-Raf Kinase Inhibitors as Anticancer Agents.

Authors:  Vivek Asati; Sanjay K Bharti; Debarshi K Mahapatra
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

9.  Cancer and renal insufficiency results of the BIRMA study.

Authors:  N Janus; V Launay-Vacher; E Byloos; J-P Machiels; L Duck; J Kerger; W Wynendaele; J-L Canon; W Lybaert; J Nortier; G Deray; H Wildiers
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

10.  Renal Function and All-Cause Mortality Risk Among Cancer Patients.

Authors:  Yan Yang; Hui-Yan Li; Qian Zhou; Zhen-Wei Peng; Xin An; Wei Li; Li-Ping Xiong; Xue-Qing Yu; Wen-Qi Jiang; Hai-Ping Mao
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889
View more
  4 in total

1.  VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity.

Authors:  Laurence M Black; Elisa R Farrell; Daria Barwinska; Gunars Osis; Anna A Zmijewska; Amie M Traylor; Stephanie K Esman; Subhashini Bolisetty; Grace Whipple; Malgorzata M Kamocka; Seth Winfree; Daryll R Spangler; Shehnaz Khan; Abolfazl Zarjou; Tarek M El-Achkar; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-18

2.  Temporary impairment of renal function in patients with rectal cancer treated with diverting ileostomy.

Authors:  Keli Yang; Jie Zhao; Lili Chu; Minhui Hu; Wenbin Zhou; Yang Li; Xinmei Ye; Rongkang Huang; Huaiming Wang; Hui Wang
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 3.  Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI.

Authors:  Letizia De Chiara; Gianmarco Lugli; Gianluca Villa; Valentina Raglianti; Faeq Husain-Syed; Fiammetta Ravaglia; Paola Romagnani; Elena Lazzeri
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

Review 4.  Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy.

Authors:  Macus Tien Kuo; Yu-Fang Huang; Cheng-Yang Chou; Helen H W Chen
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.